Small molecules aimed at type III secretion systems to inhibit bacterial virulence.
作者信息
Tsou Lun K, Dossa Paul D, Hang Howard C
机构信息
Laboratory of Chemical Biology and Microbial Pathogenesis, The Rockefeller University, New York, NY 10065, USA.
出版信息
Medchemcomm. 2013 Jan 1;4(1):68-79. doi: 10.1039/C2MD20213A.
Abstract
摘要
相似文献
1
Small molecules aimed at type III secretion systems to inhibit bacterial virulence.
Medchemcomm. 2013 Jan 1;4(1):68-79. doi: 10.1039/C2MD20213A.
2
Detection of type III secretion genes as a general indicator of bacterial virulence.
Mol Cell Probes. 2003 Feb;17(1):25-32. doi: 10.1016/s0890-8508(02)00108-1.
3
Chemical Targeting and Manipulation of Type III Secretion in the Phytopathogen Xanthomonas campestris for Control of Disease.
Appl Environ Microbiol. 2020 Jan 21;86(3). doi: 10.1128/AEM.02349-19.
4
Targeting bacterial virulence: inhibitors of type III secretion in Yersinia.
Chem Biol. 2003 Mar;10(3):241-9. doi: 10.1016/s1074-5521(03)00046-2.
5
Two virulent sRNAs identified by genomic sequencing target the type III secretion system in rice bacterial blight pathogen.
BMC Plant Biol. 2018 Oct 16;18(1):237. doi: 10.1186/s12870-018-1470-7.
6
Transcriptional inhibitor of virulence factors in enteropathogenic Escherichia coli.
Antimicrob Agents Chemother. 2005 Oct;49(10):4101-9. doi: 10.1128/AAC.49.10.4101-4109.2005.
7
Molecular mechanisms of bacterial virulence: type III secretion and pathogenicity islands.
Emerg Infect Dis. 1996 Oct-Dec;2(4):270-88. doi: 10.3201/eid0204.960403.
8
Role of bacterial secretion systems and effector proteins - insights into Aeromonas pathogenicity mechanisms.
Acta Biochim Pol. 2020 Aug 31;67(3):283-293. doi: 10.18388/abp.2020_5410.
9
SecretEPDB: a comprehensive web-based resource for secreted effector proteins of the bacterial types III, IV and VI secretion systems.
Sci Rep. 2017 Jan 23;7:41031. doi: 10.1038/srep41031.
10
Chimeric Protein-Protein Interface Inhibitors Allow Efficient Inhibition of Type III Secretion Machinery and Virulence.
ACS Infect Dis. 2019 Nov 8;5(11):1843-1854. doi: 10.1021/acsinfecdis.9b00154. Epub 2019 Sep 27.
引用本文的文献
1
Research Progress on Small Molecular Inhibitors of the Type 3 Secretion System.
Molecules. 2022 Nov 30;27(23):8348. doi: 10.3390/molecules27238348.
2
Identification of Novel Type Three Secretion System (T3SS) Inhibitors by Computational Methods and Anti- Evaluations.
Front Pharmacol. 2021 Nov 16;12:764191. doi: 10.3389/fphar.2021.764191. eCollection 2021.
3
Fluorescence Detection of Type III Secretion Using a Glu-CyFur Reporter System in .
Microorganisms. 2020 Dec 9;8(12):1953. doi: 10.3390/microorganisms8121953.
4
Yunnan Baiyao reduces hospital-acquired pressure ulcers via suppressing virulence gene expression and biofilm formation of .
Int J Med Sci. 2019 Jul 21;16(8):1078-1088. doi: 10.7150/ijms.33723. eCollection 2019.
5
Inhibition of autotransporter biogenesis by small molecules.
Mol Microbiol. 2019 Jul;112(1):81-98. doi: 10.1111/mmi.14255. Epub 2019 May 3.
6
Epigallocatechin-3-gallate inhibits bacterial virulence and invasion of host cells.
Bioorg Med Chem. 2017 Jun 1;25(11):2883-2887. doi: 10.1016/j.bmc.2017.03.023. Epub 2017 Mar 10.
7
Global Analysis of Type Three Secretion System and Quorum Sensing Inhibition of Pseudomonas savastanoi by Polyphenols Extracts from Vegetable Residues.
PLoS One. 2016 Sep 26;11(9):e0163357. doi: 10.1371/journal.pone.0163357. eCollection 2016.
8
Considerations and caveats in anti-virulence drug development.
Curr Opin Microbiol. 2016 Oct;33:41-46. doi: 10.1016/j.mib.2016.06.001. Epub 2016 Jun 16.
9
Small-Molecule Inhibitors of the Type III Secretion System.
Molecules. 2015 Sep 23;20(9):17659-74. doi: 10.3390/molecules200917659.
10
The resveratrol tetramer (-)-hopeaphenol inhibits type III secretion in the gram-negative pathogens Yersinia pseudotuberculosis and Pseudomonas aeruginosa.
PLoS One. 2013 Dec 4;8(12):e81969. doi: 10.1371/journal.pone.0081969. eCollection 2013.
本文引用的文献
1
Stimulation of host immune defenses by a small molecule protects C. elegans from bacterial infection.
PLoS Genet. 2012;8(6):e1002733. doi: 10.1371/journal.pgen.1002733. Epub 2012 Jun 14.
2
Interactions between the microbiota and the immune system.
Science. 2012 Jun 8;336(6086):1268-73. doi: 10.1126/science.1223490. Epub 2012 Jun 6.
3
The type III secretion system as a source of novel antibacterial drug targets.
Curr Drug Targets. 2012 Mar;13(3):338-51. doi: 10.2174/138945012799424642.
4
Identification of bacterial target proteins for the salicylidene acylhydrazide class of virulence-blocking compounds.
J Biol Chem. 2011 Aug 26;286(34):29922-31. doi: 10.1074/jbc.M111.233858. Epub 2011 Jul 1.
5
Identification of small-molecule inhibitors of Yersinia pestis Type III secretion system YscN ATPase.
PLoS One. 2011;6(5):e19716. doi: 10.1371/journal.pone.0019716. Epub 2011 May 18.
6
Biogenesis, regulation, and targeting of the type III secretion system.
Structure. 2011 May 11;19(5):603-12. doi: 10.1016/j.str.2011.03.015.
7
Three-dimensional model of Salmonella's needle complex at subnanometer resolution.
Science. 2011 Mar 4;331(6021):1192-5. doi: 10.1126/science.1199358.
8
Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism.
Cell. 2011 Apr 1;145(1):39-53. doi: 10.1016/j.cell.2011.02.022. Epub 2011 Mar 3.
9
Shifting the balance: antibiotic effects on host-microbiota mutualism.
Nat Rev Microbiol. 2011 Apr;9(4):233-43. doi: 10.1038/nrmicro2536. Epub 2011 Feb 28.
10
A sorting platform determines the order of protein secretion in bacterial type III systems.
Science. 2011 Mar 4;331(6021):1188-91. doi: 10.1126/science.1201476. Epub 2011 Feb 3.
Zotero 插件